$XBIO 8-K SEC Filings

Filed On	Filing
23 Sep 2026	8-K: Regulation FD Disclosure Advancing NET - Targeted Therapies for Immune - Driven Diseases and Cancer INVESTOR PRESENTATION SEPTEMBER 2026
16 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more ______________________________________________________________________________
07 Aug 2026	8-K: Results of Operations and Financial Condition
13 May 2026	8-K: Results of Operations and Financial Condition
24 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
13 Mar 2026	8-K: Results of Operations and Financial Condition
09 Jan 2026	8-K: Other Events
11 Dec 2025	8-K: Regulation FD Disclosure
13 Nov 2025	8-K: Results of Operations and Financial Condition
14 Oct 2025	8-K: Entry into a Material Definitive Agreement; Other Events
13 Aug 2025	8-K: Results of Operations and Financial Condition
14 May 2025	8-K: Results of Operations and Financial Condition
10 Apr 2025	8-K: Changes in Registrant's Certifying Accountant
19 Mar 2025	8-K: Results of Operations and Financial Condition
13 Dec 2024	8-K: Submission of Matters to a Vote of Security Holders
13 Nov 2024	8-K: Results of Operations and Financial Condition
07 Nov 2024	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
31 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation
14 Aug 2024	8-K: Results of Operations and Financial Condition
21 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments